Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric-oxide-deficiency-induced hypertension in rats

Clinical Science

Volumn 110, Issue 2, 2006, Pages 227-233

  García Estañ, Joaquín ^a   Ortiz, M Clara ^a   O'Valle, Francisco ^b   Alcaraz, Antonia ^a   Navarro, Esther G ^a   Vargas, Félix ^b   Evangelista, Stefano ^c   Atucha, Noemí M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Menarini Ricerche spa ^*  (Italy)

Author keywords

Angiotensin converting enzyme (ACE); Arterial hypertension; NG nitro L arginine methyl ester (L NAME); Nitric oxide; Nitrotyrosine; Renal injury

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ZOFENOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GLOMERULOPATHY; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPTOPRIL; DIURETICS; DRUG THERAPY, COMBINATION; ENALAPRIL; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

EID: 32644449488     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050165     Document Type: Article

References (24)

1. Lanera, V., Navarro, J., Cachofeiro, V., García-Estañ, J. and Ruilope, L. M. (1997) Nitric oxide, the kidney and hypertension. Am. J. Hypertens. 10, 129-140
2. Navarro, J., Sánchez, A., Sáiz, J. et al. (1994) Hormonal, renal and metabolic alterations during the hypertension induced by chronic inhibition of nitric oxide in rats. Am. J. Physiol. 267, R1516-R1521
3. Fernández-Rivas, A., García-Estañ, J. and Vargas, F. (1995) Hftects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J. Hypertens. 13, 123-128
4. García-Estañ, J., Navarro, J., Atucha, N. M., Romero, J. C., Cachofeiro, V. and Lahera, V. (1996) Chronic effect of nitric oxide and prostaglandin inhibition on pressure diuresis and natriuresis in rats. Kidney Int. 49 (Suppl. 55), S141-S143
5. 1 receptors in the acute and chronic effects of nitric oxide inhibition. Am. J. Physiol. 274, R760-R766
6. Navarro, J., Maeso, R., Rodrigo, E., Muñoz-García, R., Ruilope, L. M., Lahera, V. and Cachofeiro, V. (1996) Renal and vascular consequences of the chrome nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am. J. Hypertens. 9, 1077-1083
7. Fortepiani, L. A., Rodrigo, E., Ortíz, M. C. et al. (1999) Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments. J. Am. Soc. Nephrol. 10, 21-27
8. Fortepiani, L. A., Ortiz, M. C., Atucha, N. M. and García- Estañ, J. (1999) Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of endothelin blockade. J. Hypertens. 17, 287-291
9. Kitamoto, S., Égashira, K., Kataoka, C. et al. (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J. Hypertens. 18, 1795-1800
10. W-nitro-L- arginine methyl ester. Kidney Blood Press. Res. 25, 211-216
11. Duarte, J., Jiménex, R., O'Valle, F. et al. (2002) Protective-effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J. Hypertens. 20, 1843-1854
12. Ruiz-Marcos, F. M., Ortíz, M. C., Fortepiani, L. A., Nadal, F. J., Atucha, N. M. and García-Estañ, J. (2001) Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats. Eur. J. Pharmacol. 412, 273-279
13. Iyú, D., Atucha, N. M., Martínez-Prieto, C., Ortiz, M. C. and García-Estañ, J. (2004) Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rats. Cell Commun. Signaling 2, 1
14. Zatz, R. and Baylis, C. (1998) Chronic nitric oxide inhibition model six years on. Hypertension 32, 958-964
15. De Gracia, M. C., Osuna, A., O'Valle, F. et al. (2000) Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. J. Am. Soc. Nephrol. 11, 1995-2000
16. Evangelista, S. and Manzini, S. (2005) Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril. J. Int. Med. Res. 33, 42-54
17. Chopra, M., Beswick, H., Clapperton, M., Dargie, H. J., Smith, H. J. and McMurray, J. (1992) Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulphydryl- and nonsulfhydryl-containing ACE inhibitors. J. Cardiovasc. Pharmacol. 19, 330-340
18. Moser, M. and Black, H. R. (1998) The role of combination therapy in the treatment of hypertension. Am. J. Hypertens. 11, 73S-78S
19. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254
20. Yagi, K. (1976) A simple fluorimetric assay for lipoperoxide in blood plasma. Biochem. Med. 15, 212-216
21. Gonzalez, W., Fontaine, V., Pueyo, M. E. et al. (2000) Molecular plasticity of the vascular wall during L-NAME-induced hypertension: modulation of pro-inflammatory signals. Hypertension 36, 103-109
22. Corseaux, D., Ollivier, V., Huisse, M.-G. et al. (2002) Hemostasis imbalance in an experimental hypertension model. Mol. Med. 8, 169-178
23. Ranadive, S. A., Chen, A. X. and Serajuddin, A. T. M. (1992) Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors. Pharm. Res. 9, 1480-1486
24. Cushman, D. W., Wang, F. L., Fung, W. C. et al. (1989) Comparisons 'in vitro', 'ex vivo', and 'in vivo' of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br. J. Clin. Pharmacol. 28, 115S-131S